Health Outcomes by Neighborhood - Baltimore
- Conditions
- StigmaSocial NetworksActivity SpaceDrug Abuse/DependenceHIV Status
- Registration Number
- NCT01571752
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 1651
INCLUSION CRITERIA:<br><br>The enrollment target in Phase B is 650 community-dwelling individuals (at least 325 of<br>whom we anticipate will provide 12-month Visit #2 data in our 3 main study groups).<br>Enrollment for Phase A + Phase B + Phase C =3000.<br><br> - Age at least 18 years. Rationale: Children under 18 will not be included because<br> many of the measures to be administered in this study are not validated for use with<br> children. Furthermore, the research question under investigation is the drug<br> trajectories of adults, over the age of 18. However, there is no intervention in<br> this study that is contraindicated for older adults, and given that addiction in the<br> elderly is understudied, it is important to include elderly individuals.<br><br> - Residence in Baltimore city or one of the surrounding counties. Rationale: Our<br> current geographic mapping technology currently only includes these areas.<br><br>EXCLUSION CRITERIA:<br><br>-Inability to provide informed consent.
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We will examine environmental factors that may impact initiation, addiction, and treatment seeking among the greater population at large (non-drug-users, current opioid/stimulant users, and current marijuana users);To provide neighborhood-matched control groups of non-drug-using individuals, Unclassified/former drug users, and current opioid/stimulant drug users not seeking treatment;To explore the possible role of genetics and its interplay with environment in regards to drug use initiation, addiction, and treatment seeking among the study groups;To assess, longitudinally, mediators of 12-month changes in drug-misuse status in the same three groups;To assess the accuracy of stress detection in the lab and the field by the Health Tag;To assess EMA reports of drug use and psychosocial stress as well as real-time environmental risk exposure in a non-treatment seeking and/or nondrug using population
- Secondary Outcome Measures
Name Time Method Random-signal-triggered recordings;One-day laboratory session;Clinic Compliance Visit;Brief end of day recording;30-day field study